Age-related changes in the signaling and function of vascular smooth muscle cells

被引:46
作者
Lundberg, MS [1 ]
Crow, MT [1 ]
机构
[1] NIA, Vasc Biol Unit, Cardiovasc Sci Lab, Gerontol Res Ctr,NIH, Baltimore, MD 21224 USA
关键词
atherosclerosis; vascular injury; vascular smooth muscle cells; intima; neointima; TGF-beta; 1; bFGF; PDGF; calcium; calmodulin-dependent protein kinases; integrins;
D O I
10.1016/S0531-5565(99)00036-4
中图分类号
R592 [老年病学]; C [社会科学总论];
学科分类号
03 ; 0303 ; 100203 ;
摘要
Aging is an independent risk factor for the development of atheroscelrosis, a vascular abnormality that plays a significant role in the development of many cardiovascular disorders. Animal experiments have demonstrated that aging predisposes the vasculature to advanced atherosclerotic disease and vessel injury and that this predisposition is a function of age-associated changes in the vessel wall itself. Because vascular smooth muscle cells play important roles in the pathogenesis of many vascular disorders, identifying age-associated differences in the way these cells respond to extracellular clues has been an area of active research. Currently, the most remarkable differences in intracellular signaling between vascular smooth muscle cells isolated from young and old animals are related to the control of cell migration through the CamKII pathways and the accelerated transition of older vascular smooth muscle cells from the contractile to the synthetic phenotype. These differences may be due to alternative signaling pathways revealed by the inability of older cells to respond to inhibitors, such as transforming growth factor (TGF)-beta 1, or to altered interactions with the extracellular matrix resulting from age-associated shifts in integrin expression or changes in the matrix composition of blood vessels. The exact role that thew alterations have in explaining age-associated differences in the response of the vessel wall to injury and its increased susceptibility to developing advanced atherosclerotic lesions remains to be determined but will be guided by studies on intracellular signaling mechanisms. (C) 1999 Elsevier Science Inc. All rights reserved.
引用
收藏
页码:549 / 557
页数:9
相关论文
共 39 条
[1]  
[Anonymous], NIH PUBLICATION
[2]  
[Anonymous], 1991, HYPERTENSION
[3]   Inhibition of vascular smooth muscle cell migration by peptide and antibody antagonists of the alpha(v)beta(3) integrin complex is reversed by activated calcium/calmodulin-dependent protein kinase II [J].
Bilato, C ;
Curto, KA ;
Monticone, RE ;
Pauly, RR ;
White, AJ ;
Crow, MT .
JOURNAL OF CLINICAL INVESTIGATION, 1997, 100 (03) :693-704
[4]   INTRACELLULAR SIGNALING PATHWAYS REQUIRED FOR RAT VASCULAR SMOOTH-MUSCLE CELL-MIGRATION - INTERACTIONS BETWEEN BASIC FIBROBLAST GROWTH-FACTOR AND PLATELET-DERIVED GROWTH-FACTOR [J].
BILATO, C ;
PAULY, RR ;
MELILLO, G ;
MONTICONE, R ;
GORELICKFELDMAN, D ;
GLUZBAND, YA ;
SOLLOTT, SJ ;
ZIMAN, B ;
LAKATTA, EG ;
CROW, MT .
JOURNAL OF CLINICAL INVESTIGATION, 1995, 96 (04) :1905-1915
[5]  
Bilato C, 1996, AGING CLIN EXP RES, V8, P221
[6]   Phenotypic heterogeneity of rat arterial smooth muscle cell clones - Implications for the development of experimental intimal thickening [J].
BochatonPiallat, ML ;
Ropraz, P ;
Gabbiani, F ;
Gabbiani, G .
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 1996, 16 (06) :815-820
[7]   THE PHENOTYPES OF SMOOTH-MUSCLE EXPRESSED IN HUMAN ATHEROMA [J].
CAMPBELL, GR ;
CAMPBELL, JH .
ANNALS OF THE NEW YORK ACADEMY OF SCIENCES, 1990, 598 :143-158
[8]  
CROW MT, 1996, CELLULAR AGING CELL, P81
[9]   MITOGEN ACTIVATED PROTEIN (MAP) KINASE TRANSFORMS TAU-PROTEIN INTO AN ALZHEIMER-LIKE STATE [J].
DREWES, G ;
LICHTENBERGKRAAG, B ;
DORING, F ;
MANDELKOW, EM ;
BIERNAT, J ;
GORIS, J ;
DOREE, M ;
MANDELKOW, E .
EMBO JOURNAL, 1992, 11 (06) :2131-2138
[10]  
Ferng W. R., 1991, Numerical Algorithms, V1, P1, DOI 10.1007/BF02145580